Terms: = Liver cancer AND RAD21, HR21, 5885, ENSG00000164754, KIAA0078, FLJ25655, hHR21, MCD1, O60216, NXP1, HRAD21, FLJ40596, SCC1 AND Treatment
3 results:
1. The Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced Prostate cancer.
Jin WH; Zhang L; Graf R; Raskina K; Tukachinsky H; Huang RSP; McGregor K; Alshalalfa M; Hougen HY; Khan A; Punnen S; Schrock AB; Venstrom J; Mahal BA
Clin Genitourin Cancer; 2024 Feb; 22(1):e163-e169.e1. PubMed ID: 37978032
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Significance of Serum Biomarkers in Stage IV Non-Small-Cell Lung cancer Treated with PD-1 Inhibitors: LIPI Score, NLR, dNLR, LMR, and PAB.
Chen J; Wei S; Zhao T; Zhang X; Wang Y; Zhang X
Dis Markers; 2022; 2022():7137357. PubMed ID: 35945957
[TBL] [Abstract] [Full Text] [Related]
3. MiR-320b/rad21 axis affects hepatocellular carcinoma radiosensitivity to ionizing radiation treatment through DNA damage repair signaling.
Wang J; Zhao H; Yu J; Xu X; Jing H; Li N; Tang Y; Wang S; Li Y; Cai J; Jin J
Cancer Sci; 2021 Feb; 112(2):575-588. PubMed ID: 33251678
[TBL] [Abstract] [Full Text] [Related]
